Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 6.50 ($0.08) and last traded at GBX 6.88 ($0.09), with a volume of 457023 shares. The stock had previously closed at GBX 6.75 ($0.08).
Ondine Biomedical Stock Performance
The company has a current ratio of 2.34, a quick ratio of 8.26 and a debt-to-equity ratio of 24.39. The firm has a 50-day simple moving average of GBX 9.13 and a two-hundred day simple moving average of GBX 9.39. The company has a market capitalization of £15.59 million, a price-to-earnings ratio of -110.90 and a beta of -0.14.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- Following Congress Stock Trades
- Comprehensive Analysis of PayPal Stock
- Insider Buying Explained: What Investors Need to Know
- Intuitive Surgical Stock Can Trend Much Higher This Year
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
